The SH3 domain of αII spectrin is a target for the fanconi anemia protein, FANCG

Biochemistry

Volumn 48, Issue 2, 2009, Pages 254-263

  Lefferts, Joel A ^a,b   Wang, Chuan ^a   Sridharan, Deepa ^a   Baralt, Melissa ^a   Lambert, Muriel W ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONSENSUS SEQUENCES; DNA REPAIR PROCESS; FANCONI ANEMIAS; IN CELLS; INTERSTRAND CROSS-LINKS; OVERLAPPING REGIONS; REPAIR PROTEINS; SITE-DIRECTED MUTAGENESIS; SPECTRIN; STRUCTURAL PROTEINS; YEAST TWO HYBRIDS;

DNA; GENES; NUCLEIC ACIDS; REPAIR;

PROTEINS;

BRCA2 PROTEIN; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP C PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP E PROTEIN; FANCONI ANEMIA GROUP F PROTEIN; FANCONI ANEMIA GROUP G PROTEIN; FANCONI ANEMIA GROUP L PROTEIN; FODRIN; PROTEIN FANCB; PROTEIN FANCI; PROTEIN FANCJ; PROTEIN FANCM; PROTEIN FANCN; PROTEIN SH3; UNCLASSIFIED DRUG; BETA GALACTOSIDASE; FANCG PROTEIN, HUMAN; SPECTRIN;

ARTICLE; BINDING SITE; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA CROSS LINKING; DNA REPAIR; FANCONI ANEMIA; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TARGETING; SITE DIRECTED MUTAGENESIS; TWO HYBRID SYSTEM; AMINO ACID SEQUENCE; CHEMISTRY; ESCHERICHIA COLI; GENETICS; METABOLISM; MOLECULAR GENETICS; REPORTER GENE; SRC HOMOLOGY DOMAIN;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; BETA-GALACTOSIDASE; CONSENSUS SEQUENCE; ESCHERICHIA COLI; FANCONI ANEMIA COMPLEMENTATION GROUP G PROTEIN; GENES, REPORTER; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; SPECTRIN; SRC HOMOLOGY DOMAINS; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 59849090474     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi801483u     Document Type: Article

References (60)

1. Auerbach, A. D., Buchwald, M., and Joenje, H. (2002) Fanconi anemia, in The Genetic Basis of Human Cancer (Vogelstein, B., and Kinzler, K. W., Eds.) 2nd ed., pp 317-332, McGraw-Hill, New York.
2. Joenje, H., and Patel, K. J. (2001) The emerging genetic and molecular basis of Fanconi anaemia. Nat. ReV. Genet. 2, 446-457.
3. Kennedy, R. D., and D'Andrea, A. D. (2005) The Fanconi anemia/BRCA pathway: new faces in the crowd. Genes DeV. 19, 2925-2940.
4. Taniguchi, T., and D'Andrea, A. D. (2006) Molecular pathogenesis of Fanconi anemia: recent progress. Blood 107, 4223-4233.
5. Papadopoulo, D., Averbeck, D., and Moustacchi, E. (1987) The fate of 8-methoxypsoralen-photoinduced DNA interstrand crosslinks in Fanconi's anemia cells of defined genetic complementation groups. Mutat. Res. 184, 271-280.
6. Lambert, M. W., Tsongalis, G. J., Lambert, W. C., Hang, B., and Parrish, D. D. (1992) Defective DNA endonuclease activities in Fanconi's anemia cells, complementation groups A and B. Mutat. Res. 273, 57-71.
7. Lambert, M. W., Tsongalis, G J., Lambert, W. C., and Parrish, D. D. (1997) Correction of the DNA repair defect in Fanconi anemia complementation groups A and D cells. Biochem. Biophys. Res. Commun. 230, 587-591.
8. Brois, D. W., McMahon, L. W., Ramos, N. I., Anglin, L. M., Walsh, C. E., and Lambert, M. W. (1999) A deficiency in a 230 kDa DNA repair protein in Fanconi anemia complementation group A cells is corrected by the FANCA cDNA. Carcinogenesis 20, 1845-1853.
9. Kumaresan, K. R., and Lambert, M. W. (2000) Fanconi anemia, complementation group A, cells are defective in ability to produce incisions at sites of psoralen interstrand cross-links. Carcinogenesis 21, 741-751.
10. Niedernhofer, L. J., Lalai, A. S., and Hoeijmakers, J. H. (2005) Fanconi anemia (cross)linked to DNA repair. Cell 123, 1191-1198.
11. Kumaresan, K. R., Sridharan, D. M., McMahon, L. W., and Lambert, M. W. (2007) Deficiency in incisions produced by XPF at the site of a DNA interstrand cross-link in Fanconi anemia cells. Biochemistry 46, 14359-14368.
12. McMahon, L. W., Walsh, C. E., and Lambert, M. W. (1999) Human R spectrin II and the Fanconi anemia proteins FANCA and FANCC interact to form a nuclear complex. J. Biol. Chem. 274, 32904-32908.
13. McMahon, L. W., Sangerman, J., Goodman, S. R., Kumaresan, K., and Lambert, M. W. (2001) Human R spectrin II and the FANCA, FANCC, and FANCG proteins bind to DNA containing psoralen interstrand cross-links. Biochemistry 40, 7025-7034.
14. Sridharan, D., Brown, M., Lambert, W. C., McMahon, L. W., and Lambert, M. W. (2003) Nonerythroid αII spectrin is required for recruitment of FANCA and XPF to nuclear foci induced by DNA interstrand cross-links. J. Cell Sci. 116, 823-835.
15. Sridharan, D. M., McMahon, L. W., and Lambert, M. W. (2006) αII-Spectrin interacts with five groups of functionally important proteins in the nucleus. Cell Biol. Int. 30, 866-878.
16. Lefferts, J. A., and Lambert, M. W. (2003) Fanconi anemia cell lines deficient in αII spectrin express normal levels of αII spectrin mRNA. Biochem. Biophys. Res. Commun. 307, 510-515.
17. Goodman, S. R., Zimmer, W. E., Clark, M. B., Zagon, I. S., Barker, J. E., and Bloom, M. L. (1995) Brain spectrin: of mice and men. Brain Res. Bull. 36, 593-606.
18. Morrow, J. S., Rimm, D. L., Kennedy, S. P., Cianci, C. D., Sinard, J. H., and Weed, S. A. (1997) Of membrane stability and mosaics: the spectrin cytoskeleton, in Handbook of Physiology (Hoffman, J., and Jamieson, J., Eds.) pp 485-540, Oxford, London.
19. De Matteis, M. A., and Morrow, J. S. (2000) Spectrin tethers and mesh in the biosynthetic pathway. J. Cell Sci. 113, 2331-2343.
20. Gascard, P., and Mohandas, N. (2000) New insights into functions of erythroid proteins in nonerythroid cells. Curr. Opin. Hematol. 7, 123-129.
21. Bennett, V., and Baines, A. J. (2001) Spectrin and ankyrin-based pathways: metazoan inventions for integrating cells into tissues. Physiol. Rev. 81, 1353-1392.
22. Young, K. G., and Kothary, R. (2005) Spectrin repeat proteins in the nucleus. BioEssays 27, 144-152.
23. Yamashita, T., Kupfer, G. M., Naf, D., Suliman, A., Joenje, H., Asano, S., and D'Andrea, A. D. (1998) The Fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation. Proc. Natl. Acad. Sci. U.S.A. 95, 13085-13090.
24. Cesareni, G., Panni, S., Nardelli, G., and Castagnoli, L. (2002) Can we infer peptide recognition specificity mediated by SH3 domains? FEBS Lett. 513, 38-44.
25. Yu, H., Chen, J. K., Feng, S., Dalgarno, D. C., Brauer, A. W., and Schreiber, S. L. (1994) Structural basis for the binding of proline-rich peptides to SH3 domains. Cell 76, 933-945.
26. Feng, S., Chen, J. K., Yu, H., Simon, J. A., and Schreiber, S. L. (1994) Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science 266, 1241-1247.
27. Lim, W. A., Richards, F. M., and Fox, R. O. (1994) Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains. Nature 372, 375-379.
28. Mayer, B. J., and Eck, M. J. (1995) SH3 domains. Minding your p's and q's. Curr. Biol. 5, 364-367.
29. Rickles, R. J., Botfield, M. C., Zhou, X. M., Henry, P. A., Brugge, J. S., and Zoller, M. J. (1995) Phage display selection of ligand residues important for Src homology 3 domain binding specificity. Proc. Natl. Acad. Sci. U.S.A. 92, 10909-10913.
30. Kay, B. K., Williamson, M. P., and Sudol, M. (2000) The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J. 14, 231-241.
31. Casares, S., Lopez-Mayorga, O., Vega, M. C., Camara-Artigas, A., and Conejero-Lara, F. (2007) Cooperative propagation of local stability changes from low-stability and high-stability regions in a SH3 domain. Proteins 67, 531-547.
32. Huber, P. A., Medhurst, A. L., Youssoufian, H., and Mathew, C. G (2000) Investigation of Fanconi anemia protein interactions by yeast two-hybrid analysis. Biochem. Biophys. Res. Commun. 268, 73-77.
33. Hussain, S., Witt, E., Huber, P. A., Medhurst, A. L., Ashworth, A., and Mathew, C. G. (2003) Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. Hum. Mol. Genet. 12, 2503-2510.
34. Hussain, S., Wilson, J. B., Blom, E., Thompson, L. H., Sung, P., Gordon, S. M., Kupfer, G M., Joenje, H., Mathew, C. G., and Jones, N. J. (2006) Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2. DNA Repair 5, 629-640.
35. Wasenius, V. M., Saraste, M., Salven, P., Eramaa, M., Holm, L., and Lehto, V. P. (1989) Primary structure of the brain alpha-spectrin. J. Cell. Biol. 108, 79-93.
36. Winkelmann, J. C., and Forget, B. G. (1993) Erythroid and nonerythroid spectrins. Blood 81, 3173-3185.
37. Ziemnicka-Kotula, D., Xu, J., Gu, H., Potempska, A., Kim, K. S., Jenkins, E. C., Trenkner, E., and Kotula, L. (1998) Identification of a candidate human spectrin Src homology 3 domain-binding protein suggests a general mechanism of association of tyrosine kinases with the spectrin-based membrane skeleton. J. Biol. Chem. 273, 13681-13692.
38. Musacchio, A., Gibson, T, Lehto, V. P., and Saraste, M. (1992) SH3 - an abundant protein domain in search of a function. FEBS Lett. 307, 55-61.
39. Cohen, G B., Ren, R., and Baltimore, D. (1995) Modular binding domains in signal transduction proteins. Cell 80, 237-248.
40. Kuriyan, J., and Cowburn, D. (1997) Modular peptide recognition domains in eukaryotic signaling. Annu. Rev. Biophys. Biomol. Struct. 26, 259-288.
41. Stein, R. (1998) SH2 and SH3 domains. Unraveling signaling networks with peptide antagonists. Methods Mol. Biol. 88, 187-195.
42. McPherson, P. S. (1999) Regulatory role of SH3 domain-mediated protein-protein interactions in synaptic vesicle endocytosis. Cell Signall. 11, 229-238.
43. Ren, R., Mayer, B. J., Cicchetti, P., and Baltimore, D. (1993) Identification of a ten-amino acid proline-rich SH3 binding site. Science 259, 1157-1161.
44. Mayer, B. J. (2001) SH3 domains: complexity in moderation. J. Cell Sci. 114, 1253-1263.
45. Musacchio, A., Noble, M., Pauptit, R., Wierenga, R., and Saraste, M. (1992) Crystal structure of a Src-homology 3 (SH3) domain. Nature 359, 851-855.
46. Musacchio, A., Saraste, M., and Wilmanns, M. (1994) High-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline-rich peptides. Nat. Struct. Biol. 1, 546-551.
47. 15N NMR assignment and solution structure of the SH3 domain of spectrin: comparison of unrefined and refined structure sets with the crystal structure. J. Biomol. NMR 9, 347-357.
48. Sadqi, M., Casares, S., Abril, M. A., Lopez-Mayorga, O., Conejero-Lara, F., and Freire, E. (1999) The native state conformational ensemble of the SH3 domain from α-spectrin. Biochemistry 38, 8899-8906.
49. Feng, S., Kasahara, C., Rickles, R. J., and Schreiber, S. L. (1995) Specific interactions outside the proline-rich core of two classes of Src homology 3 ligands. Proc. Natl. Acad. Sci. U.S.A. 92, 12408-12415.
50. Medhurst, A. L., Huber, P. A. J., Waisfisz, Q., de Winter, J. P., and Mathew, C. G (2001) Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway. Hum. Mol. Genet. 10, 423-429.
51. Harris, A. S., Croall, D. E., and Morrow, J. S. (1988) The calmodulin-binding site in α-fodrin is near the calcium-dependent protease-I cleavage site. J. Biol. Chem. 263, 15754-15761.
52. Huh, G. Y., Glantz, S. B., Je, S., Morrow, J. S., and Kim, J. H. (2001) Calpain proteolysis of αII-spectrin in the normal adult human brain. Neurosci. Lett. 316, 41-44.
53. Simonovic, M., Zhang, Z., Cianci, C. D., Steitz, T. A., and Morrow, J. S. (2006) Structure of the calmodulin αII-spectrin complex provides insight into the regulation of cell plasticity. J. Biol. Chem. 281, 34333-34340.
54. Glantz, S. B., Cianci, C. D., Iyer, R., Pradhan, D., Wang, K. K., and Morrow, J. S. (2007) Sequential degradation of αII and βII spectrin by calpain in glutamate or maitotoxin-stimulated cells. Biochemistry 46, 502-513.
55. Williams, S. T., Smith, A. N., Cianci, C. D., Morrow, J. S., and Brown, T. L. (2003) Identification of the primary caspase 3 cleavage site in alpha II-spectrin during apoptosis. Apoptosis 8, 353-361.
56. Harris, A. S., and Morrow, J. S. (1988) Proteolytic processing of human brain alpha spectrin (fodrin): identification of a hypersensitive site. J. Neurosci. 8, 2640-2651.
57. Harris, A. S., Croall, D. E., and Morrow, J. S. (1989) Calmodulin regulates fodrin susceptibility to cleavage by calcium-dependent protease I. J. Biol. Chem. 264, 17401-17408.
58. Nicolas, G., Fournier, C. M., Galand, Malbert-Colas, L., Bournier, O., Kroviarski, Y., Bourgeois, M., Camonis, J. H., Dhermy, D., Grandchamp, B., and Lecomte, M. C. (2002) Tyrosine phosphorylation regulates alpha II spectrin cleavage by calpain. Mol. Cell. Biol. 22, 3527-3536.
59. Nedrelow, J. H., Cianci, C. D., and Morrow, J. S. (2003) c-Src binds αII spectrin's Src homology 3 (SH3) domain and blocks calpain susceptibility by phosphorylating Tyr1176. J. Biol. Chem. 278, 7735-7741.
60. Viguera, A. R., Arrondo, J. L., Musacchio, A., Saraste, M., and Serrano, L. (1994) Characterization of the interaction of natural proline-rich peptides with five different SH3 domains. Biochemistry 33, 10925-10933.